Urgent.News

What's breaking now, across thousands of outlets.

More in Business

GC Cell Presents GCC2005 Phase 1a Progress

GC Cell has shared clinical progress on 'GCC2005,' an allogeneic CAR-NK cell therapy it is developing for the treatment of refractory T-cell lymphoma, on the international stage.The company said it…

  • GC Cell presented Phase 1a interim results for GCC2005 at Eastern Breeze Symposium in October 2026
  • Symposium marked 20th anniversary of Lymphoma Working Party of Korean Society of Hematology
  • GC Cell conducting domestic Phase 1b trial to expedite commercialization of GCC2005

More from Wednesday 28 October →